Interní Med. 2009; 11(9): 414-417

Wegener´s granulomatosis from point of view of the pulmologist

MUDr. Vladimíra Lošťáková, Ph.D1, prof. MUDr. Vítězslav Kolek DrSc1, MUDr. Stanislav Losse1, doc. MUDr. Pavel Horák CSc2, MUDr. Tomáš Tichý3, MUDr. Vladimír Benýšek4
1 Klinika plicních nemocí a tuberkulózy, FN a LF UP Olomouc
2 III. interní klinika FN a LF UP Olomouc
3 Ústav patologie FN a LF UP Olomouc
4 Radiologická klinika FN a LF UP Olomouc

There are presented the basic principles of diagnostic and treatment of Wegener´s granulomatosis. The authors present the group of 23

pacients with Wegener´s granulomatosis who were treated at Department of pneumology and tubeculosis LF Olomouc in the period of

1980–2009. The diagnosis was determined on the basis of current clasiffication, histological examination supported with characteristic

clinical and radiologic findings. The treatment was proceed by actual standards. The authors underline interdepartmental aproach

towards care of this multiorgan disease.

Keywords: Wegener´s granulomatosis, diagnostic, therapy.

Published: October 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lošťáková V, Kolek V, Losse S, Horák P, Tichý T, Benýšek V. Wegener´s granulomatosis from point of view of the pulmologist. Interní Med. 2009;11(9):414-417.
Download citation

References

  1. Wegener F. Über generalisirte, septische gefasserkrankungen. Verhandlungers der Deutschen Gesselschaft für Pathologie 1936; 29: 202-209.
  2. Lane SE, at al. Epidemiology of systemic vasculitis. Curr. Rheum. Reports 2005; 7: 270-275. Go to original source... Go to PubMed...
  3. Lane SE, at al. Are environmental factors important in primary systemic vasculitis. Arthritis Rheum 2003; 48: 814-843. Go to original source... Go to PubMed...
  4. Al Maini M, Carrete S. Diagnosis of Wegener´s Granulomatosis in the ANCA Er. J. Rheumatol. 2006; 33: 2060-2063. Go to PubMed...
  5. Koldingsness W, Nossent H. Epidemiology of Wegenerś granulomatosis in northern Norway. Arthritis Rheum 2004; 43: 2481-2487. Go to original source...
  6. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000; 43: 414-419. Go to original source...
  7. Erickson VR, Hwang PH. Curr Opin Otolaryngol Head Neck Surg. 2007; 15: 170-176. Go to original source... Go to PubMed...
  8. Bečvář R, Tesař V, Rychlík I. Vaskulitidy v klinické praxi- diagnostika a terapie. Praha, Medprint, 1994: 65-68.
  9. Seo P, Stone JH. The antineutrophil Cytoplasmic AntibodyAssociated Vasculitides. AM J Med. 2002; 117: 39-50. Go to original source... Go to PubMed...
  10. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitides. Arthritis Rheum. 1990; 33: 1122-1128. Go to original source... Go to PubMed...
  11. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192. Go to original source... Go to PubMed...
  12. De Remme RA, Donald TJ, Weiland LM. Wegener´s granulomatosis: experience with over 100 cases. New approaches yor treatment. Sarcoicosis. 1986; 3: 143-144.
  13. Frazier AA, Rosado-de-Christenson MI, Galvin JR, Fleming MV. Pulmonary Angiitis and Granulomatosis: Radiolog-Pathologic Correlation. radioGraphiccs. 1998; 18: 688-697. Go to original source... Go to PubMed...
  14. White ES, Lunch JP. Pharmacological Therapy for Wegenerś Granulomatosis. 2006. Go to original source...
  15. Borgmann S, Haubitz M. Genetic impact of pathogenesis and prognosis of ANCA - associated vasculitides. Clin Exp Rheumatol 2004; 36: 79-86.
  16. Lošťáková V, Kolek V. Aspergilová pneumonie u nemocného s inumodeficitem. Stud. Pneumol. Phtiseol. 2003; 63: 181-184.
  17. Lošťáková V, Tichý T, Kolek V. Plicní granulomatózy spojené s angiitidou. Kazuistiky v alergologii, pneumologii, 2008; 5: 16-17.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.